Empagliflozin, calcium, and SGLT1/2 receptor affinity: another piece of the puzzle-Reference-Cited by-同舟云学术

Empagliflozin, calcium, and SGLT1/2 receptor affinity: another piece of the puzzle

Published:2018-07-19 Issue:4 Volume:5 Page:549-551
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Anker Stefan D.¹²,Butler Javed³

Affiliation:

1. Division of Cardiology and Metabolism, Department of Cardiology (CVK), Berlin-Brandenburg Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin; Charité Universitätsmedizin Berlin; Berlin Germany

2. Department of Cardiology and Pneumology; University Medicine Göttingen (UMG); Göttingen Germany

3. Department of Medicine; University of Mississippi; Jackson MS USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ehf2.12345/fullpdf

Reference15 articles.

1. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015

2. Reduction in cardiovascular (CV) death with empagliflozin is consistent across categories of baseline HbA1c and change in HbA1c: results from EMPA-REG OUTCOME;Inzucchi;Diabetes,2017

3. The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors;Butler;Eur J Heart Fail,2017

4. Effects of sodium-glucose cotransporter 2 inhibitors for the treatment of patients with heart failure: proposal of a novel mechanism of action;Packer;JAMA Cardiol,2017

5. Associations of dipeptidyl peptidase-4 inhibitors with mortality in hospitalized heart failure patients with diabetes mellitus;Sato;ESC Heart Fail,2016

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the anti-cancer potential of SGLT2 inhibitors in breast cancer treatment in pre-clinical and clinical studies;European Journal of Pharmacology;2024-09

2. SGLT2 inhibitors: how do they affect the cardiac cells;Molecular and Cellular Biochemistry;2024-08-19

3. Pharmacological Treatment of Diabetes Mellitus: An Overview of New Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Diabetes Mellitus;Journal of Endocrinology and Metabolism;2024-06

4. Sodium glucose cotransporter-2 inhibitors and heart disease: Current perspectives;World Journal of Cardiology;2024-05-26

5. The interplay between sodium/glucose cotransporter type 2 and mitochondrial ionic environment;Mitochondrion;2024-05